Related Experiment Video
Updated: Jun 17, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
ETS-1 oncogenic activity mediated by transforming growth factor alpha
Chet E Holterman1, Aleksandra Franovic, Josianne Payette
1Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada K1H 8M5.
Cancer Research
|January 14, 2010
Summary
The oncogene Ets-1 drives cancer growth by regulating transforming growth factor alpha (TGFalpha). Inhibiting Ets-1 blocks tumor formation, while restoring TGFalpha rescues proliferation, revealing a key cancer mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Inappropriate Ets-1 expression is linked to human cancers, contributing to cell transformation and tumor formation.
- The precise mechanism by which Ets-1 promotes autonomous cancer cell growth remains incompletely understood.
Purpose of the Study:
- To elucidate the role of Ets-1 in conferring autonomous growth and proliferation in cancer cells.
- To identify downstream targets of Ets-1 involved in oncogenesis.
Main Methods:
- Utilized various cancer cell lines to study the effects of Ets-1 inhibition.
- Conducted screens of diffusible growth factors to identify Ets-1-regulated pathways.
- Employed gene silencing and rescue experiments to validate findings.
Main Results:
- Ets-1 inhibition effectively blocked tumor formation and cell proliferation in vivo and autonomous growth in vitro.
- Specific downregulation of transforming growth factor alpha (TGFalpha) was observed upon Ets-1 inhibition.
- Ets-1 directly binds to and regulates the promoter region of TGFalpha.
- Restoring TGFalpha expression rescued tumor cell proliferation and autonomous growth in Ets-1-silenced cells.
Conclusions:
- Ets-1 promotes cancer cell proliferation and autonomous growth by upregulating TGFalpha.
- This study reveals a novel mechanism of Ets-1 oncogenic activity in human cancers via TGFalpha regulation.
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...